A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human CIP2A The CIP2A Recombinant Protein Antigen is derived from E. coli. The CIP2A Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-050807 |
|---|
| Réf. fabricant | 18190818 |
|---|
| Méthode de purification | >80% by SDS-PAGE and Coomassie blue staining |
|---|
| Nom usuel | KIAA1524 Recombinant Protein Antigen |
|---|
| Contenu et stockage | Store at −20°C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS and 1M Urea, pH 7.4 |
|---|
| À utiliser avec (application) | AC |
|---|
| Alias de gène | Cancerous inhibitor of PP2A, CIP2A, FLJ12850, KIAA1524, MGC163436, p90 autoantigen |
|---|
| Symbole de gène(s) | CIP2A |
|---|
| Type d’étiquette | Unlabeled |
|---|
| Poids moléculaire | 29 kDa |
|---|
| Type de produit | Recombinant Protein Antigen |
|---|
| Quantité | 0.1mL |
|---|
| État réglementaire | RUO |
|---|
| Source | E.coli |
|---|
| Réactivité spécifique | This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-53710. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
